Quick answers
- What is Urocit-K?
- Urocit-K is a brand name of Potassium citrate, a prescription medicine. The FDA NDC Directory lists 2 Urocit-K products in 2 strengths and forms.
- Who makes Urocit-K?
- Mission Pharma holds the FDA application for Urocit-K (NDA019071, approved August 30, 1985).
- Is there a generic or store brand of Urocit-K?
- Yes. The FDA NDC Directory lists 26 other products with the same active ingredients, strength and form as a Urocit-K product, 26 of them generic. Ask your pharmacist whether one is right for you.
- Has Urocit-K been recalled?
- No recall linked to Urocit-K products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Urocit-K is
Each Urocit-K product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Potassium citrate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| potassium citrate 10 meq tablet, extended release (oral) | Urocit-K | 15 products, 10 companies | DailyMed |
| potassium citrate 15 meq tablet, extended release (oral) | Urocit-K | 11 products, 8 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Potassium citrate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA019071 | Mission Pharma | August 30, 1985 | 2 |
Companies that list Urocit-K
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Urocit-K products.
- Mission Pharmacal Company2 products
Recalls
No recall linked to Urocit-K products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.